EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY-NC-SA 4.0

Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy

Danuta Szczesna-Cordary iD

Journal of General Physiology · 2024

DOI: 10.1085/jgp.202413640 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of General Physiology, 2024. Verfasst von Danuta Szczesna-Cordary. Beteiligte Einrichtung: Department of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Cardiac Myosins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New RLC-1 small-molecule inhibits actomyosin interactions, reduces contractile force, and speeds up myosin cross-bridge kinetics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicCardiac MyosinsHumansAnimalsBenzylaminesUracil

Substanzen

Cardiac MyosinsMYK-461BenzylaminesUracil

Autor:innen und Institutionen

  • Department of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, USA.

ORCID-Profile: Danuta Szczesna-Cordary

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Szczesna-Cordary, D. (2024). Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy. Journal of General Physiology. https://doi.org/10.1085/jgp.202413640

Vancouver

Szczesna-Cordary D. Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy. Journal of General Physiology. 2024. doi:10.1085/jgp.202413640

BibTeX
@article{SzczesnaCordary2024,
  author = {Szczesna-Cordary, Danuta},
  title = {Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy},
  journal = {Journal of General Physiology},
  year = {2024},
  doi = {10.1085/jgp.202413640}
}
Kostenlos starten →